JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hong, S. L.
Right arrow Articles by Deykin, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hong, S. L.
Right arrow Articles by Deykin, D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J. Biol. Chem., Vol. 255, Issue 20, 9538-9540, Oct, 1980

Tranylcypromine and 15-hydroperoxyarachidonate affect arachidonic acid release in addition to inhibition of prostacyclin synthesis in calf aortic endothelial cells

SL Hong, T Carty and D Deykin

In this paper, we examined the effect of two known inhibitors of prostacyclin synthetase, tranylcypromine and 15- hydroperoxyarachidonate, on bradykinin-stimulated prostacyclin synthesis and arachidonic acid release from cellular phospholipids in endothelial cells derived from calf aorta. These two inhibitors inhibit prostacyclin synthesis stimulated by bradykinin, arachidonic acid, and ionophore A23187. However, these two inhibitors also affect the release of arachidonic acid from cells. Using cells prelabeled with [3H]arachidonic acid, we found that bradykinin-stimulated arachidonic acid release is severely inhibited by tranylcypromine (500 microgram/ml) but is stimulated by 15-hydroxyperoxyarachidonate at a concentration as low as 1 microgram/ml. We also found that 15- hydroperoxyarachidonate inhibits not only prostacyclin formation but also prostaglandin formation from the released arachidonic acid. Under the conditions used, these two compounds have no effects on the cell viability as judged by trypan blue exclusion test. We conclude that tranylcypromine and 15-hydroperoxyarachidonate not only inhibit prostacyclin synthesis but also affect other steps in the metabolism of arachidonic acid in whole cells.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
F. Merhi-Soussi, Z. Dominguez, O. Macovschi, M. Dubois, A. Savany, M. Lagarde, and A.-F. Prigent
Human lymphocytes stimulate prostacyclin synthesis in human umbilical vein endothelial cells. Involvement of endothelial cPLA2
J. Leukoc. Biol., December 1, 2000; 68(6): 881 - 889.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1980 by the American Society for Biochemistry and Molecular Biology.